1. /
  2. About us /
  3. Our people and structure /
  4. Our people /
  5. Tim Spelman
Our people

Tim Spelman

Biostatistician

Working groups

tim.spelman@burnet.edu.au
Tim Spelman

Burnet publications

View 124 more
25 Jun 2025

Varicella zoster virus reactivation episodes and vaccination uptake in Spleen Australia registrants

Vaccine

Gabriela Khoury, Tim Spelman

Open access
01 Jun 2025

Evaluation of a telehealth service to support breast cancer prevention medication uptake: a protocol of a mixed methods study

BMJ Open

Tim Spelman

Open access
31 May 2025

Kinetics and predictors of Hepatitis B surface antigen (HBsAg) loss after commencing HBV-active antiretroviral therapy (ART) in the setting of HIV-and chronic HBV co-infection

Clinical Infectious Diseases

Tim Spelman

Current projects

Achieving the final phases of hepatitis C elimination using innovative models of care

Achieving the final phases of hepatitis C elimination using innovative models of care

We're identifying innovative models of care so that no-one misses out on HCV care in Australia and globally.

Using ultraviolet light to reduce COVID-19 in aged care homes (ELUCIDAR study)

Using ultraviolet light to reduce COVID-19 in aged care homes (ELUCIDAR study)

Ultraviolet light has been used for decades to disinfect the air and prevent disease. This study explores using UV light to reduce COVID-19 infection in residential aged care facilities.

Past projects

The Optimise Study: Optimising Isolation, Quarantine and Distancing for COVID-19

The Optimise Study: Optimising Isolation, Quarantine and Distancing for COVID-19

This project aims to find out how Victorians are experiencing COVID-19 and responding to the measures introduced to stop the spread of the virus.

News and features

NHMRC funding boost for hepatitis C elimination

NHMRC funding boost for hepatitis C elimination

Burnet will use the AUD$5 million to identify new ways of engaging the estimated 70,000 Australians living with Hepatitis C virus to receive care.

On this page